CLINICAL RESPONSE, EFFECTIVENESS, SAFETY AND MUCOSAL HEALING INDUCTION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A PRELIMINARY REAL-LIFE MULTICENTRIC EXPERIENCE IN SOUTHERN ITALY

被引：0
|
作者：
Contaldo, A. [1 ]
Losurdo, G. [1 ]
Bossa, F. [2 ]
Biscaglia, G. [2 ]
Mazzuoli, S. [3 ]
Fanigliulo, L. [4 ]
Tursi, A. [5 ]
Lovero, R. [1 ]
Ierardi, E. [1 ]
Principi, M. B. [1 ]
Di Leo, A. [1 ]
机构：
[1] Univ Policlin Bari, UOC Gastroenterol, Bari, Italy
[2] Casa Sollievo Sofferenza, UOC Gastroenterol, San Giovanni Rotondo, Italy
[3] Osped S Nicola Pellegrino, UOC Gastroenterol, Trani, Italy
[4] SS Annunziata Hosp, Gastroenterol Unit, Taranto, Italy
[5] ASL BAT, Gastroenterol Serv, Barletta, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 02期
关键词：
D O I：
10.1016/S1590-8658(18)30562-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.07.12
引用
收藏
页码：E198 / E198
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
    Gonzalez Munoza, C.
    Mesonero, F.
    Bargallo, A.
    Clos, A.
    Arajol, C.
    Gordillo, J.
    Lopez-San Roman, A.
    Guardiola, J.
    Navarro-Llavat, M.
    Bertoletti, F.
    Fernandez, C.
    Domenech, E.
    Garcia-Planella, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S486 - S486
  • [2] Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
    Holvoet, Tom
    Truyens, Marie
    De Galan, Cara
    Peeters, Harald
    Gismero, Francisco Mesonero
    Elorza, Ainara
    Torres, Paola
    Vandermeulen, Liv
    Jauregui-Amezaga, Aranzazu
    Ferreiro-Iglesias, Rocio
    Zabana, Yamile
    Reverter, Laia Peries
    Geldof, Jeroen
    Lobaton, Triana
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [3] Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience
    Calvo Moya, M. I.
    Omella Usieto, I.
    Vera Mendoza, M. I.
    Matallana Royo, V.
    Gonzalez Partida, I.
    Manso Manrique, M.
    Menchen Viso, B.
    Tellez de Meneses, R. De Lucas
    Gonzalez Rodriguez, M.
    Bella del Castillo, P.
    Gonzalez Lama, Y.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S355 - S355
  • [4] Efficacy of Vedolizumab as Induction Therapy for Inflammatory Bowel Disease in a 'real-life' Study
    Trefois, Quentin
    Descamps, Olivier
    Coche, Jean-Charles
    Schapira, Michael
    ACTA CLINICA BELGICA, 2016, 71 : 7 - 7
  • [5] Predictors of vedolizumab response to induction: Real-life experience
    Gutierrez, A.
    Sempere, L.
    Belvis, M.
    Vazquez, J. M.
    Laveda, R.
    Garcia, M.
    Arguelles-Arias, F.
    Pallares, H.
    Castro, L.
    Gomez, E.
    Maldonado, B.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S297 - S297
  • [6] Effectiveness and safety of vedolizumab for the induction of remission in inflammatory bowel disease
    Chaparro, M.
    Sierra-Ausin, M.
    Mesonero, F.
    Maroto, N.
    Fernandez de Castro, C.
    Garcia-Sanchez, V.
    Lucendo, A. J.
    Busquets, D.
    Barreiro-de Acosta, M.
    Marin-Jimenez, I.
    Beltran, B.
    Ruiz Belmonte, L.
    Bermejo, F.
    Minguez, M.
    Pajares, R.
    Pineda, J. R.
    Sicilia, B.
    Martin-Rodriguez, D.
    Gutierrez, A.
    Rubio, S.
    Garcia Tercero, I.
    Piqueras, M.
    Ginard, D.
    Jucha, B.
    Munoz Villafranca, C.
    Martin-Arranz, M. D.
    Marti Romero, L.
    Fernandez Bonilla, E. M.
    Echarri, A.
    Forcelledo, J. F.
    Donday, M. G.
    Ramas, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S416 - S417
  • [7] Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experience
    Pestour, S.
    Nancey, S.
    Charlois, A. L.
    Bonaz, B.
    Flourie, B.
    Boschetti, G.
    Mathieu, N.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S65 - S66
  • [8] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [9] Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study
    Bor, Renata
    Fabian, Anna
    Matuz, Maria
    Szepes, Zoltan
    Farkas, Klaudia
    Miheller, Pal
    Szamosi, Tamas
    Vincze, Aron
    Rutka, Mariann
    Szanto, Kata
    Balint, Anita
    Nagy, Ferenc
    Milassin, Agnes
    Toth, Tibor
    Zsigmond, Ferenc
    Bajor, Judit
    Mullner, Katalin
    Lakner, Lilla
    Papp, Maria
    Salamon, Agnes
    Horvath, Gabor
    Sarang, Krisztina
    Schafer, Eszter
    Sarlos, Patricia
    Palatka, Karoly
    Molnar, Tamas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 205 - 213
  • [10] Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice
    Ylisaukko-oja, Tero
    Torvinen, Saku
    Aaltonen, Jaakko
    Nuutinen, Heikki
    Blomster, Timo
    Jussila, Airi
    Pajala, Markku
    Salminen, Kimmo
    Moilanen, Veikko
    Hakala, Kalle
    Kellokumpu, Mikko
    Toljamo, Kari
    Rautiainen, Henna
    Kuisma, Juha
    Peraaho, Markku
    Molander, Pauliina
    Silvennoinen, Jouni
    Liukkonen, Ville
    Henricson, Hans
    Tillonen, Jyrki
    Esterinen, Mirva
    Nielsen, Christian
    Hirsi, Eija
    Laane, Margus
    Suhonen, Ulla-Maija
    Vihriala, Ilkka
    Makela, Petri
    Puhto, Mika
    Punkkinen, Jari
    Sulonen, Hannu
    Herrala, Sauli
    Jokelainen, Jari
    Tamminen, Klaus
    Sipponen, Taina
    BIOLOGICALS, 2019, 58 : 50 - 56
12345